A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease

Journal of Neurology

Volumn 244, Issue 6, 1997, Pages 349-359

  Varma, Anoop R ^a   Talbot, Paul R ^a   Snowden, Julie S ^a   Lloyd, James J ^a   Testa, Humberto J ^a   Neary, David ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Alzheimer's disease; Lewy body disease; Single photon emission computed tomography

Indexed keywords

TECHNETIUM 99M; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; OXIME; TECHNETIUM COMPLEX;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ASYMMETRY; BRAIN BLOOD FLOW; BRAIN CORTEX; COGNITIVE DEFECT; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; LANGUAGE DISABILITY; LEWY BODY; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PRIORITY JOURNAL; PSYCHOPATHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; PARKINSON DISEASE; SCINTISCANNING;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; OXIMES; PARKINSON DISEASE; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030610254     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050101     Document Type: Article

References (57)

1. Agniel A, Celcis P, Viallard G, Montastruc JL, Rascol O, Demonet JF, Marc-Vergnes JP, Ruscol A (1991) Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. J Neurol Neurosurg Psychiatry 54: 783-786
2. Brun A, England B, Gustafson L, Passant U, Mann DMA, Neary D, Snowden JS (1994) Clinical and neuropathological criteria tor frontotemporal dementia. J Neurol Neurosurg Psychiatry 57: 416-418
3. Burns A, Philpol MP, Costa DC, Ell PJ, Levy R (1989) The investigation of Alheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry 52: 248-253
4. Byrne EJ, Lennox GG, Lowe J, Godwin-Austin RB (1989) Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 52: 709-717
5. Byrne EJ, Lennox GG, Godwin-Austin RB, Jefferson D, Lowe J, Mayer RJ, Landon M, Doherty TJ (1991) Dementia associated with cortical Lewy bodies: proposed clinical diagnostic crtieria. Dementia 2: 283-284
6. Chang LT (1978) A method of attentuation correction in radionuclide computed tomography. Trans Nucl Sci 25: 638-643
7. 99mTc-HMPAO in patients with dementia (Alzheimer type and HIV) and Parkinson's disease - initial results. J Cereb Blood Flow Metab. 8: 109-115
8. Cummings JL, Benson DF (1984) Subcortical dementia. Review of an emerging concept. Arch Neurol 41: 874-879
9. Dickson DW, Crystal H, Mattiace LA, Kress Y, Schwagerl A, Ksiezak-Reding H, Davies P, Yen S-HC (1989) Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (Berl) 78: 572-584
10. Dickson DW, Ruan D, Crystal H, Mark MH, Davies P, Kress Y, Yen S-HC (1992) Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 41: 1402-1409
11. Eagger S, Syed GMS, Burns A, Barrett JJ, Levy R (1992) Morphologic (CT) and functional (rCBF-SPECT) correlates in Alzheimer's disease. Nucl Med Commun 13: 644-647
12. Eberling JL, Richardson BC, Reed BR, Wolfe N, Jagust WJ (1994) Cortical glucose metabolism in Parkinson's disease without dementia. Neurobiol Aging 15: 329-335
13. Filley CM (1995) Neuropsychiatric features of Lewy body disease. Brain Cogn 28: 229-239
14. Forstl H, Burns A, Luthert P, Cairns N, Levy R (1993) The Lewy body variant of Alzheimer's disease. Clinical and pathological findings. Br J Psychiatry 162: 385-392
15. Gibb WRG, Esiri MM, Lees AJ (1985) Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia) Brain 110: 1131-1153
16. Globus M, Mildworf B, Melamed E (1985) Cerebral blood flow and cognitive impairment in Parkinson's disease. Neurology 35: 1135-1139
17. Godfrey K (1985) Statistics in practice: comparing the means of several groups. N Engl J Med 313: 1450-1456
18. Goto I, Taniwaki T, Hosokawa S, Otsuka M, Ichiya Y, Ichimiya A (1993) Positron emission tomographic (PET) studies in dementia. J Neurol Sci 114: 1-6
19. Hansen L, Salmon D, Galasko D, Masliah E, Kalzman R, DeTereas R, Thai L, Pay MM, Hofsletter R, Klauher M, Rice V, Butters N, Alford M (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 40: 1-8
20. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-patliological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
21. Ince P, Irving D, MacArthur F, Perry RH (1991) Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer-type, senile dementia of Lewy body type. Parkinson's disease and non-demented elderly control patients. J Neurol Sci 106: 142-152
22. Jagust WJ, Reed BR, Martin EM, Eberling JL, Nelson-Abbott RA (1992) Cognitive function and regional cerebral blood flow in Parkinson's disease. Brain 115: 521-537
23. 18F] Fluorodeoxyglucose method. Ann Neurol 15: 419-424
24. Lennox G, Lowe J, Landon M, Byrne EJ, Mayer RJ, Godwin-Austen RB (1989) Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 52: 1236-1247
25. Lenzi GL, Jones T, Reid JL, Moss S (1979) Regional impairment of cerebral oxidative metabolism in Parkinson's disease. J Neurol Neurosurg Psychiatry 42: 59-62
26. Levy R, Bagger S, Griffiths M, Perry E, Honovar M, Dean A, Lantos P (1994) Lewy bodies and response to tacrine in Alzheimer's disease. Lancet 343: 176
27. Lippa CF, Smith TW, Swearer JM (1994) Alzheimer's disease and Lewy body disease: a comparative clinico-pathological study. Ann Neurol 35: 81-88
28. m-HMPAO in Alzheimer's disease. Nucl Med Commun 13: 535-541
29. m-HMPAO SPECT in Parkinson's disease. Nucl Med Commun 13: 744-748
30. Mann DMA (1991) The topographical distribution of brain pathology in Alzheimer's disease. Acta Neuropathol (Berl) 83: 81-86
31. Mann DMA, Snowden JS (1995) The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol (Berl) 89: 178-183
32. Markus HS, Costa DC, Lees AJ (1994) HMPAO SPECT in Parkinson's disease before and after levodopa: correlation with dopaminergic responsiveness. J Neurol Neurosurg Psychiatry 57: 180-185
33. Markus HS, Lees AJ, Lennox G, Marsden CD, Costa DC (1995) Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls. Mov Disord 10: 179-187
34. Masdeu JC, Van Heertum RL, Yudd A, Anselmi G (1991) Single-photon emission computed tomography findings in unilateral parkinsonism. J Neuroimaging 1: 200-202
35. McKeith IG, Perry RH, Fairbairn AF, Jabeen S, Perry EK (1992) Operational criteria for senile dementia of Lewy body type (SDLT) Psychol Med 22: 911-922
36. McKeith IG, Fairbairn AF, Perry RH, Thompson P, Perry EK (1992) Neuroleptic sensitivity in patients with senile dementia of the Lewy body type. BMJ 305: 673-678
37. McKeith IG, Bartholomew PH, Irvine EM (1993) Single photon emission tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. Br J Psychiatry. 163: 597-603
38. McKeith IG, Fairbairn AF, Perry RH, Thompson P (1994) The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT) Br J Psychiatry 165: 324-332
39. McKhann G, Dutchman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ARDRA Working Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944
40. Montaldi D, Brooks DN, McColl JH (1990) Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 53: 33-38
41. Neary D, Snowden JS, Bowen DM, Sims NR, Mann DMA, Benton JS, Northen B, Yates PO, Davison AN (1986) Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry 49: 163-174
42. 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry 50: 1101-1109
43. Perry RH, Irving D, Blessed G, Fairbairn AF, Perry EK (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 95: 119-139
44. Pizzolato G, Dam M, Borsato N (1988) (99mTc)-HM-PAO SPECT in Parkinson's disease. J Cereb Blood Flow Metab S101-108
45. Sawada H, Udaka F, Kameyama M, Seiu N, Nishinaka K, Shindou K, Kodama M, Nishitani N, Okumiya K (1992) SPECT findings in Parkinson's disease associated with dementia. J Neurol Neurosurg Psychiatry 55: 960-963
46. Smith FW, Gemmell HG, Sharp PF, Besson JAO (1988) Technetium-99m HMPAO imaging in patients with basal ganglia disease. Br J Radiol 61: 914-920
47. Snowden JS, Neary D, Mann DMA, Goulding PJ, Testa HJ (1992) Progressive language disorder due to lobar atrophy. Ann Neurol 31: 174-183
48. 99mTc)-HM-PAO SPECT and cognitive impairment in Parkinson's diseuse: a comparison with dementia of the Alzheimer type. J Neurol Neurosurg Psychiatry 54: 787-792
49. Tachibana H, Kawabata Y, Tomino Y, Sugito M, Fukuchi M (1993) Brain perfusion imaging in Parkinson's disease and Alzheimer's disease demonstrated by three-dimentional surface display with 1231-Iodoamphetamine. Dementia 4: 334-341
50. Talbot PR, Lloyd JJ, Snowden JS, Neary D, Testa HJ (1994) The choice of reference region in the quantification of SPET in primary degenerative dementia. Eur J Nucl Med 21: 503-508
51. Talbot PR, Snowden JS, Lloyd JJ, Neary D, Testa HJ (1995) The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disease. J Neurol 242: 579-586
52. Talbot PR, Goulding PJ, Snowden JS, Lloyd JJ, Neary D, Testa HJ (1995) Inter-relation between 'classic' motor neuron disease and fronto-temporal dementia: a neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry 58: 541-547
53. Trojanowski JQ, Schmidt ML, Shin RW, Bramlett GT, Rao D, Lee VM-Y (1993) Altered tau and neurofilament proteins in neurodegenertive disease: diagnostic implications for Alzheimer's disease and Lewy body dementias. Brain Pathol 3: 45-54
54. 123I-QNB and single-photon emission computed tomography. Arch Neurol 49: 169-176
55. Wilcock GK, Scott MI (1994) Tacrine for senile dementia of Alzheimer's or Lewy body type. Lancet 344: 544
56. Wolfson LI, Leenders KL, Brown LL, Jones T (1985) Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease. Neurology 35: 1399-1405
57. Wyper D, Teasdale E, Patterson J (1993) Abnormalities in rCBF and computed tomography in patients with Alzheimer's disease and in controls. Br J Radiology. 66: 23-37